-
AMRI Named Exclusive API Supplier for Recently Approved Acne Treatment
contractpharma
November 09, 2020
Albany Molecular Research, Inc. (AMRI) has been named as the exclusive supplier of the active pharmaceutical ingredient (API) in Cassiopea SpA’s recently approved acne treatment, Winlevi (clascoterone) cream 1%.
-
India is a key market for us, it is a pharma centre of excellence
expresspharma
November 09, 2020
Alessandra Vizza, Regional Business Director, Corning Reactor Technologies talks about Advanced-Flow Reactors (AFR) and explains how it can help Indian pharma companies upscale their production output by providing continuous process production capacity ..
-
Slow CMO revenue growth could impact US
europeanpharmaceuticalreview
November 06, 2020
Dose contract manufacturing organisations (CMOs) had slow revenue growth in 2019, a trend continuing into 2020 that could impact the US.
-
Eurofins CDMO Expands Drug Product Capabilities in Canada
contractpharma
November 06, 2020
Eurofins CDMO has expanded its existing drug product operation capabilities with the early 2020 completion of its new drug product development and cGMP manufacturing facility, located in Mississauga, Canada.
-
Lasa gets environmental clearance for benzimidazole derivatives capacity expansion at Khed facility
expresspharma
November 06, 2020
Lasa’s total volumetric capacity to increase by ~60 per cent to 6,800 TPA.
-
Reducing API dependence: Have we got the strategy right?
expresspharma
November 04, 2020
Reji K Joseph, Associate Professor, Institute for Studies in Industrial Development, New Delhi explains that the PLI scheme has some gaps that need to be plugged for it to be truly successful.
-
Pharma industry appreciates modification in PLI scheme, seek more support
expresspharma
November 02, 2020
The industry also raises concerns related to brownfield investments, protection of indigenous manufacturing.
-
Aarti Drugs to expand metformin capacity to 3000 TPM
expresspharma
November 02, 2020
Aarti Drugs has procured land to expand its existing Metformin Capacity to 3000 TPM in a brownfield expansion. This expansion would be a two-phase expansion program.
-
CordenPharma Colorado Completes Highly Potent API Lab Expansion
contractpharma
October 21, 2020
CordenPharma has completed a new highly potent active pharmaceutical ingredient (API) laboratory in its Boulder, CO, facility.
-
Biopharma companies more optimistic about 2020 imports/exports than in Q1: GlobalData
expresspharma
October 19, 2020
API manufacturing still remains a greater concern than finished dose due to the high volume of small molecule API produced in China and India for cost reasons.